The elucidation of the molecular mechanisms of brain tumor biology requires accurate and relevant models. Important new research demonstrates that multi-passaged tumor cell lines, used for years for both in vitro assays and for xenograft transplants in vivo, exhibit significant variation in gene expression and phenotypic characteristics when compared with the parent tumor from which they were originally derived. This progressive divergence of tumor cell lines from primary phenotype and genotype has profound implications for the application of both basic and preclinical studies. A candidate cell to replace these traditional lines is the proposed “cancer initiating cell,” or “cancer stem cell” a precursor cell isolated from solid brain tumors which appears capable both of self-perpetuation and differentiation in permissive conditions. In a recent study by Lee et al. in Cancer Cell (9:5, 391–403, 2006), CD133+ tumor stem cells were isolated from GBMs and compared with existing cell lines. These stem cells were found to resemble neural stem cells and primary tumor more closely than traditional GBM cell lines. Tumor cells grown in the presence of EGF and bFGF, without serum, expressed neural stem cell markers, maintained proliferative capacity, and demonstrated neural and glial differentiation upon transfer to serum culture. In contrast, tumor cells grown in serum did not possess NSC markers, did not maintain the capacity for differentiation, and demonstrated irregular growth patterns. With respect to tumorigenicity, these tumor stem cells produced brain tumors in neonatal SCID mice even after several passages, with histology, growth pattern, and genetic expression all mimicking human GBM (Figure). Cells cultured with serum were only tumorigenic following late passage, and harbored gene mutations that progressively diverged from the parent GBM.Figure: Phenotypic characterization of tumors derived from tumor stem cell compared with late passage serum-cultured GBM cells A–C: Representative microphotographs of intracranial xenograft tumor (A), serum-cultured cell-derived tumor (B), tumor generated from U87MG glioma cell lines (C). Note the extensive infiltration into the surrounding cerebral cortex in A only. Tu indicates central tumor mass. D–F: Infiltrative/migratory nature of xenograft tumors diffusely infiltrate adjacent cortex (D) and migrated along the corpus callosum (E) and olfactory bulb (F). Inset in F is a hematoxylin/eosin (H/E)-stained section depicting normal olfactory bulbs. LV in D indicates lateral ventricle. G–I: Immunohistochemical staining of tumors by antibodies for Nestin (G), Sox2 (H), and G FA P (I).The results of this study indicate that TSCs can be isolated from primary brain tumors and that these TSCs maintain stem cell characteristics in vitro, possess the ability to recapitulate the parent tumor xenographically, and exhibit a gene expression profile similar to that of human GBM. The use of TSCs as a more appropriate clinical model of study as compared to current tumor cell lines is an important and exciting new prospect in the field of neurosurgery as the origins and therapeutic approach to brain tumors continue to be explored. JEFFREY P. G REENFIELD M.D., Ph.D. CAITLIN HOFFMAN, B.S. JOHN A BOOCKVAR, M.D. STEM CELL RESEARCH
Read full abstract